Related Experiment Video
Updated: Nov 18, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
[NCTD Retards AML HL60 Cell Proliferation via Targeting Hedgehog/SOX2 axis]
Ming-Yan Fu1, Wei-Wei Chen1, Na Gao1
1Department of Hematology, Cancer Research Institute, Binzhou Medical University Hospital, Binzhou 256600, Shandong Province, China.
Objective:
To investigate the effect of norcantharidin (NCTD) to proliferation of leukemia cells through disrupting key regulators of sonic Hedgehog (SHH) pathway and its downstream transcription factor SOX2.
Methods:
CCK8 was used to detected the HL60 and NB4 cells after inhibited by NCTD, SMO and GLI1 inhibitor for 24 hours. Expression level of SMO, GLI1 and SOX2 in HL60 cells with NCTD treatment was detected by immunoblot. HL60 cells were transfected with pcDNA3.1 plasmid expressing GLI1 or SOX2. Empty vector and pcDNA3. 1-EGFP were divided into negative and positive control group, respectively. The expression of exogenous GLI1 or SOX2 in HL60 cells was confirmed by immunoblot, and growth curve of HL60 cell was checked by CCK8. Proliferation of genetic modified HL60 cells treated by various dose of NCTD was detected.
Results:
NCTD, SMO/GLI1 inhibitors could inhibit the proliferation of NB4 and HL60 cells in a dose-dependent manner. Compared with solvent (DMSO)-treated control group, NCTD remarkably decreased protein level of SMO, GLI1 and SOX2. GLI1 and SOX2 were overexpressed in HL60 cells as compared with pcDNA3.1 empty vector-transfected group. Growth curve demonstrated significant proliferative advantage of GLI1/SOX2-transfected cells. CCK8 assay indicated that GLI1/SOX2-overexpressed HL60 cells were more resistant to NCTD treatment.
Conclusion:
NCTD attenuates HL60 proliferation via targeting the Hedgehog/SOX2 axis.
Insights
Norcantharidin (NCTD) inhibits leukemia cell growth by targeting the Hedgehog/SOX2 pathway. This compound reduces proliferation and affects key regulators like SMO and GLI1 in leukemia cells.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- The sonic Hedgehog (SHH) pathway plays a role in cell proliferation and is implicated in various cancers, including leukemia.
- SOX2 is a transcription factor downstream of the SHH pathway, often overexpressed in cancers.
- Norcantharidin (NCTD) is a derivative of cantharidin with potential anti-cancer properties.
Purpose of the Study:
- To investigate the effect of norcantharidin (NCTD) on leukemia cell proliferation.
- To determine if NCTD disrupts the sonic Hedgehog (SHH) pathway and its downstream target SOX2.
- To explore the role of the SHH/SOX2 axis in NCTD's anti-leukemic activity.
Main Methods:
- Cell Counting Kit-8 (CCK8) assays were used to assess the proliferation of HL60 and NB4 leukemia cells.
- Western blotting was employed to detect protein expression levels of SMO, GLI1, and SOX2 after NCTD treatment.
- HL60 cells were genetically modified to overexpress GLI1 or SOX2 to study their impact on proliferation and NCTD resistance.
Main Results:
- NCTD and inhibitors of SMO/GLI1 significantly inhibited HL60 and NB4 cell proliferation in a dose-dependent manner.
- NCTD treatment led to a remarkable decrease in the protein levels of SMO, GLI1, and SOX2 in HL60 cells.
- Overexpression of GLI1 or SOX2 in HL60 cells conferred a proliferative advantage and increased resistance to NCTD treatment.
Conclusions:
- Norcantharidin (NCTD) effectively attenuates leukemia cell proliferation.
- NCTD exerts its anti-leukemic effect by targeting the Hedgehog/SOX2 signaling axis.
- The SHH/SOX2 pathway is a critical regulator of leukemia cell growth and response to NCTD.
Related Concept Videos
Hedgehog Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
Inhibition of Cdk Activity
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

